La maladie de Parkinson en France (serveur d'exploration) - Corpus (PubMed)

Index « MedMesh.i » - entrée « Randomized Controlled Trials as Topic »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Random Allocation < Randomized Controlled Trials as Topic < Range of Motion, Articular  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 14.
Ident.Authors (with country if any)Title
000436 (2015) Guillaume Lamotte ; Miriam R. Rafferty ; Janey Prodoehl ; Wendy M. Kohrt ; Cynthia L. Comella ; Tanya Simuni ; Daniel M. CorcosEffects of endurance exercise training on the motor and non-motor features of Parkinson's disease: a review.
000517 (2014) Olivier RascolParkinson disease: Can a new trial end controversy over when to use levodopa?
000606 (2014) Anna Castrioto ; Eugénie Lhommée ; Elena Moro ; Paul KrackMood and behavioural effects of subthalamic stimulation in Parkinson's disease.
000634 (2014) Thomas F. WhayneIschemic heart disease and the Mediterranean diet.
000863 (2012) Santiago Perez-Lloret ; María Ver Nica Rey ; Estelle Dellapina ; Jean Pellaprat ; Christine Brefel-Courbon ; Olivier RascolEmerging analgesic drugs for Parkinson's disease.
000961 (2011) Claire Thiriez ; Gabriel Villafane ; Frédérique Grapin ; Gilles Fenelon ; Philippe Remy ; Pierre CesaroCan nicotine be used medicinally in Parkinson's disease?
000A19 (2011) Christine A M. Payan ; François Viallet ; Bernhard G. Landwehrmeyer ; Anne-Marie Bonnet ; Michel Borg ; Franck Durif ; Lucette Lacomblez ; Frédéric Bloch ; Marc Verny ; Jacques Fermanian ; Yves Agid ; Albert C. Ludolph ; Peter N. Leigh ; Gilbert BensimonDisease severity and progression in progressive supranuclear palsy and multiple system atrophy: validation of the NNIPPS--Parkinson Plus Scale.
000A33 (2010) Olivier Rascol[Disease-modifying therapies in PD].
000C15 (2009) Olivier Rascol"Disease-modification" trials in Parkinson disease: target populations, endpoints and study design.
000C38 (2009) Alim Louis Benabid ; Stephan Chabardes ; John Mitrofanis ; Pierre PollakDeep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease.
001060 (2003) Patrice BoyerSense and non-sense of polypharmacy: increasing efficacy, decreasing compliance?
001175 (2002) Selegiline: a second look. Six years later: too risky in Parkinson's disease.
001190 (2002) Olivier Rascol ; Christopher Goetz ; William Koller ; Werner Poewe ; Cristina SampaioTreatment interventions for Parkinson's disease: an evidence based assessment.
001700 (1993) C. Daubert ; P. Mabo ; D. Gras ; C. LeclercqClinical role of d-sotalol and d,l-sotalol in supraventricular arrhythmias, including pre-excitation.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i -k "Randomized Controlled Trials as Topic" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i  \
                -Sk "Randomized Controlled Trials as Topic" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Randomized Controlled Trials as Topic
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024